🇺🇸 FDA
Patent

US 10857139

Substituted diazaspiroalkanes as androgen receptor modulators

granted A61KA61K31/4439A61K9/48

Quick answer

US patent 10857139 (Substituted diazaspiroalkanes as androgen receptor modulators) held by The Regents of the University of California expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4439, A61K9/48, A61P, A61P13/08